Skip to main content

Table 1 Clinical characteristic of normal control, normalbuminuria, microalbuminuria and macroalbuminuria patients

From: Differential urinary glycoproteome analysis of type 2 diabetic nephropathy using 2D-LC–MS/MS and iTRAQ quantification

Characteristics

Normal control (n = 16)

Normalbuminuria (group I) (n = 7)

Microalbuminuria (group II) (n = 8)

Macroalbuminuia (group III) (n = 8)

Gender (M/F)

8/8

3/4

5/3

4/4

Age (years)

47.25 ± 1.79

52.43 ± 2.91

47.33 ± 2.33

50.82 ± 1.7

BMI (mg/m2)

21.37 ± 0.43

25.77 ± 1.67a

25.28 ± 1.51c

24.39 ± 0.84

SCr (μmol/L)

76.85 ± 1.64

73.71 ± 4.13

84.78 ± 4.37

111.91 ± 4.31e

BUN (mmol/L)

5.16 ± 0.28

5.05 ± 0.59

4.78 ± 0.70

7.41 ± 0.41e

UAE (μg/min)

9.19 ± 0.96

6.81 ± 1.47

114.77 ± 17.63d

1489.2 ± 502.6e

eGFR (mL/min)

91.52 ± 2.62

90.66 ± 5.48

86.77 ± 5.54

57.58 ± 3.69e

TG (mmol/L)

0.88 ± 0.08

1.16 ± 0.14

2.03 ± 0.41d

1.58 ± 0.14f

SBP (mmHg)

119.33 ± 2.52

117.14 ± 5.96

123.89 ± 4.7

133.73 ± 4.41f

DBP (mmHg)

76.6 ± 1.64

74.29 ± 2.97

79.44 ± 4.12

80 ± 3.3

LDL (mmol/L)

3.31 ± 0.25

2.97 ± 0.27

3.27 ± 0.29

3.2 ± 0.24

HDL (mmol/L)

1.64 ± 0.06

1.31 ± 0.12

1.12 ± 0.1d

1.29 ± 0.08f

FBG (mmol/L)

5.01 ± 0.09

9.24 ± 1.17b

9.07 ± 0.58d

8.85 ± 0.64e

HBA1C (%)

n.a.

8.19 ± 0.62

8.76 ± 0.62

8.71 ± 0.44

  1. SCr serum creatinine, BUN blood urea nitrogen, UAE urine albumin, eGFR estimated glomerular filtration rate, TG triglyceride, SBP systolic blood pressure, DBP diastolic blood pressure, LDL low-density lipoprotein, HDL high-density lipoprotein, FBG fasting blood glucose, HBA1C glycatedhaemoglobin
  2. a P < 0.05 between for normalbuminuria versus normal control
  3. b P < 0.001 for normalbuminuria versus normal control
  4. c P < 0.05 for microalbuminuria versus normal control
  5. d P < 0.001 for microalbuminuria versus normal control
  6. e P < 0.001 for macroalbuminuria versus normal control
  7. f P < 0.05 for macroalbuminuria versus normal control